Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Zydus
FDA Approves ARSENIC TRIOXIDE — Zydus Pharmaceuticals USA Inc.

# FDA Approves Arsenic Trioxide Generic from Zydus Pharmaceuticals The FDA has approved Zydus Pharmaceuticals USA Inc.'s generic arsenic trioxide int...

ALVOGEN
FDA Approves Unknown Drug — ALVOGEN

ALVOGEN announced on November 8, 2018, the approval of its Abbreviated New Drug Application (ANDA208540), signaling the company's strategic expansion ...

Camber
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals, Inc. received FDA approval for Abbreviated New Drug Application #211487 covering hydrocodone bitartrate and acetaminophen oral...

UNICHEM
FDA Approves SOTALOL HYDROCHLORIDE AF — UNICHEM PHARMACEUTICALS (USA), INC.

Unichem Pharmaceuticals (USA), Inc. announced today the receipt of approval for ANDA207429 to manufacture the oral tablets of Sotalol Hydrochloride, a...

AUROLIFE
FDA Approves Unknown Drug — AUROLIFE PHARMA LLC

Here are two sentences for a financial newswire: AUROLIFE PHARMA LLC capitalizes on market share by securing FDA approval for N/A, advancing its entr...

Ascend
FDA Approves METFORMIN HYDROCHLORIDE — Ascend Laboratories, LLC

FDA approved the ANDA for Metformin Hydrochloride manufactured by Ascend Laboratories, LLC, granting the firm market authorization for the generic ver...

U.S.
FDA Approves TALZENNA — U.S. Pharmaceuticals

On October 16, 2018, U.S. Pharmaceuticals received FDA approval for Talzenna (talazoparib tosylate), a targeted oral therapy for advanced breast cance...

Camber
FDA Approves ATOVAQUONE — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals, Inc. received FDA approval for oral atovaquone, reinforcing market expectations for increased generic penetration and pressure...

Paratek
FDA Approves NUZYRA — Paratek Pharmaceuticals, Inc.

On October 2, 2018, Paratek Pharmaceuticals received FDA approval for NUZYRA (omadacycline), an oral antibiotic poised to address treatment gaps cause...

Paratek
FDA Approves NUZYRA — Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals received FDA approval on October 2, 2018, to market the intravenous antibiotic NUZYRA (omadacycline) under New Drug Applicatio...

Insmed
FDA Approves ARIKAYCE — Insmed Incorporated

Brookline, Massachusetts-based Insmed Incorporated announced Wednesday that JAMA reports suggest the amikacin inhaled formulation ARIKAYCE could impro...

Eli
FDA Approves EMGALITY — Eli Lilly and Company

On September 27, 2018, Eli Lilly and Company received FDA approval for the brand-name treatment EMGALITY (galcanezumab-gnlm), a structural analog of g...

Epic
FDA Approves METFORMIN HYDROCHLORIDE — Epic Pharma, LLC

FDA granted approval Tuesday to Epic Pharma for a generic ANDA filing, adding another formulation of metformin hydrochloride to the schedule of availa...

Fresenius
FDA Approves PALONOSETRON — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC announced the approval of generic palonosetron hydrochloride by the FDA on September 19, 2018, offering a less expensive alter...

Fresenius
FDA Approves PALONOSETRON — Fresenius Kabi USA, LLC

Fresenius Kabi USA has secured FDA approval to manufacture the anti-emetic drug palonsetron hydrochloride under ANDA 206802. This approval introduces ...

Teva
FDA Approves AJOVY — Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals USA, Inc. announced FDA approval for Fremanezumab subcutaneously, a move poised to intensify competitive pricing in the migraine ...

Breckenridge
FDA Approves EPLERENONE — Breckenridge Pharmaceutical, Inc.

Breckenridge Pharmaceuticals has secured FDA approval for ANDA 208283 regarding oral eplerenone, introducing an additional generic option that is expe...

Merck
FDA Approves DELSTRIGO — Merck Sharp & Dohme LLC

Merck Sharp & Dohme (MSD) announced the FDA approval of Brand DELSTRIGO, a single-tablet regimen combining doravirine, lamivudine, and tenofovir disop...

Upsher-Smith
FDA Approves DILTIAZEM HYDROCHLORIDE — Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories, LLC has received approval for its Abbreviated New Drug Application (ANDA) 205231 to manufacture generic DILTIAZEM HYDROCHLO...

Laurus
FDA Approves METFORMIN HYDROCHLORIDE — Laurus Labs Limited

Laurus Labs Limited received FDA approval on August 27, 2018, for its ANDA209882 to manufacture the oral tablet formulation of Metformin Hydrochloride...